Hims & Hers Health, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NYSE
SCHEDULE: Hims & Hers CEO Boosts Stake to 10.3%
Andrew Dudum, CEO of Hims & Hers Health, Inc., has updated his beneficial ownership to 10.3% of the Class A common stock, reflecting a significant insider stake.